Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis.
Steg
R E
RE
Department of Neurology, Creighton University School of Medicine, Omaha, NE 68131-2197.
Lefkowitz
D M
DM
D000328:Adult; D002544:Cerebral Infarction / Q000209:etiology*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D009157:Myasthenia Gravis / Q000628:therapy*
D016756:Immunoglobulins, Intravenous